sponsored byAAAS Golden Fund

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 851-875 out of 1318.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 > >>

Public Release: 8-Sep-2015
European Congress on Tropical Medicine and International Health ECTMIH
Clinical trial for first oral drug candidate specifically developed for sleeping sickness
The Drugs for Neglected Diseases initiative has announced today at the 9th European Congress on Tropical Medicine and International Health in Basel, Switzerland, the successful completion of Phase I human clinical trials for SCYX-7158 (AN5568), the first oral drug candidate specifically developed from the earliest drug discovery stage to combat human African trypanosomiasis, or sleeping sickness, a deadly parasitic disease transmitted by the tsetse fly.

Contact: Violaine Dällenbach
vdallenbach@dndi.org
41-794-241-474
Drugs for Neglected Diseases Initiative

Public Release: 8-Sep-2015
PLOS ONE
Umeå researcher explains the increase in dengue epidemics in Singapore
Population growth and increased temperature are the most important explanations to the significant increase of dengue incidence in Singapore since the 1970s. This is shown in a study undertaken by Joacim Rocklöv and his colleagues at the unit of Epidemiology and Global Health at Umeå University in Sweden, published in the journal PLOS ONE.

Contact: Mattias Grundström Mitz
46-907-866-465
Umea University

Public Release: 8-Sep-2015
Dissertations
Swedish surgical research stops suffering for millions of impoverished citizens
Mosquito mesh cannot just prevent malaria, but can also be used to reduce the suffering caused by groin hernia. A surgical operation using mosquito mesh to repair the hernia can give millions of people a chance at a better life. This according to a study performed in collaboration with Umeå University, Sweden.

Contact: Mattias Grundström Mitz
mattias.mitz@umu.se
46-907-866-465
Umea University

Public Release: 8-Sep-2015
JAMA
Iron supplementation during pregnancy and risk of malaria in malaria-endemic region
Among women in a malaria-endemic region in Kenya, daily iron supplementation during pregnancy did not result in an increased risk of malaria, according to a study in the Sept. 8 issue of JAMA. Iron supplementation did result in increased birth weight, gestational duration, neonatal length, and a decreased risk of low birth weight and prematurity.

Contact: Martin N. Mwangi
mart.mwangi@gmail.com
The JAMA Network Journals

Public Release: 8-Sep-2015
Scientific Reports
Nature: Study creates cell immunity to parasite that infects 50 million
Multi-institution, multidisciplinary study applies cancer science technique to field of infectious diseases to pinpoint human genes that allow parasite E. histolytica to cause cell death.
National Institutes of Health

Contact: Garth Sundem
garth.sundem@ucdenver.edu
University of Colorado Anschutz Medical Campus

Public Release: 8-Sep-2015
Health Affairs
Global health studies in September Health Affairs
The September issue of Health Affairs includes articles examining the growing burden of noncommunicable diseases, both in the United States and elsewhere.

Contact: Amy Martin Vogt
amartinvogt@gymr.com
202-745-5052
Health Affairs

Public Release: 7-Sep-2015
16th World Conference on Lung Cancer
IASLC issues new statement on tobacco control and smoking cessation
The International Association for the Study of Lung Cancer today issued a new statement on Tobacco Control and Smoking Cessation at the 16th World Conference on Lung Cancer in Denver. The statement calls for higher taxes on tobacco products, comprehensive advertising and promotion bans of all tobacco products and product regulation including pack warnings.

Contact: Jeff Wolf
Jeff.Wolf@iaslc.org
720-325-2952
International Association for the Study of Lung Cancer

Public Release: 7-Sep-2015
Proceedings of the National Academy of Sciences
Mobile phone records may predict epidemics of mosquito-borne dengue virus
A new study led by Harvard T.H. Chan School of Public Health researchers finds cell phone records can predict the geographical spread and timing of dengue epidemics. Utilizing the largest data set of cell phone records ever analyzed to estimate human mobility, the researchers developed an innovative model to predict epidemics and provide early warning to policy makers.
James S. McDonnell Foundation, Wellcome Trust, Models of Infectious Disease Agent Study

Contact: Marge Dwyer
mhdwyer@hsph.harvard.edu
617-432-8416
Harvard T.H. Chan School of Public Health

Public Release: 3-Sep-2015
PLOS ONE
Rapid testing for TB aims to reduce drug resistance, lower mortality rate
Researchers at University of California, San Diego School of Medicine have documented the accuracy of three new tests for more rapidly diagnosing drug-resistant forms of tuberculosis, which are much harder and more expensive to treat and which, experts say, represent a major threat to global public health.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 1-Sep-2015
Hepatology
Cirrhosis, antibodies increase risk of poor outcome for autoimmune hepatitis patients
New research reports that cirrhosis at first diagnosis and antibodies for the soluble liver antigen/liver pancreas antigen are major risk factors for poor short- and long-term outcome in patients with autoimmune hepatitis.

Contact: Dawn Peters
sciencenewsroom@wiley.com
781-388-8408
Wiley

Public Release: 1-Sep-2015
UC San Diego scientists investigate global hemorrhagic fever bacterial disease
An international research team, headed by Joseph Vinetz, M.D., professor of medicine at University of California, San Diego School of Medicine and director of the UC San Diego Center for Tropical Medicine and Travelers Health, has been awarded a five-year, $1.89 million cooperative agreement to carry out transnational research studies of leptospirosis, an infectious and sometimes fatal bacterial disease endemic in much of the world.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Scott LaFee
slafee@ucsd.edu
619-543-6163
University of California - San Diego

Public Release: 31-Aug-2015
Journal of Women's Health
Sex-specific biomarkers are needed to learn why heart attacks kill more women than men
Disproportionately more women than men die due to cardiovascular disease and heart attacks in the US, and current risk scoring systems -- based on factors measured mainly in male populations -- are poor predictors of mortality risk for women who suffer cardiac arrest. The need for sex-specific bio-marker and risk stratification tools to improve diagnosis and treatment is clearly described in the Editorial 'Sex, Myocardial Infarction, and the Failure of Risk Scores in Women', published in Journal of Women's Health.

Contact: Kathryn Ryan
kryan@liebertpub.com
914-740-2100
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 27-Aug-2015
Journal of General Internal Medicine
Survey finds many physicians overestimate their ability to assess patients' risk of Ebola
While most primary care physicians responding to a survey expressed confidence in their ability to identify potential cases of Ebola and communicate Ebola risks to their patients, when asked how they would care for hypothetical patients who might have been exposed to Ebola, less than 70 percent gave answers fitting CDC guidelines. Those least likely to encounter an Ebola patient were most likely to choose overly intense management of patients actually at low risk.

Contact: Mike Morrison
mdmorrison@partners.org
617-724-6425
Massachusetts General Hospital

Public Release: 27-Aug-2015
PLOS Pathogens
A patient shedding poliovirus for 28 years -- possible challenges for polio eradication
With all but two countries worldwide, Pakistan and Afghanistan, declared polio-free, the eradication of the devastating viral disease in the near future is a real possibility. A study published on Aug. 27 in PLOS Pathogens reports results from an individual in the UK with an immune disease whose stool samples have contained large amounts of live polio virus for over 20 years. Patients like this one, the authors suggest, could start new polio outbreaks and complicate polio eradication as currently planned.

Contact: Javier Martin
javier.martin@nibsc.org
44-170-764-1295
PLOS

Public Release: 26-Aug-2015
The Lancet
Life expectancy climbs globally but more time spent living with illness and disability
People around the world are living longer, even in some of the poorest countries, but a complex mix of fatal and nonfatal ailments causes a tremendous amount of health loss, according to a new analysis of all major diseases and injuries in 188 countries. Global life expectancy at birth for both sexes rose by 6.2 years, while healthy life expectancy, or HALE, at birth rose by 5.4 years.

Contact: Rhonda Stewart
stewartr@uw.edu
Institute for Health Metrics and Evaluation

Public Release: 25-Aug-2015
PLOS Medicine
Less may be more in slowing cholera epidemics
An oral cholera vaccine that is in short supply could treat more people and save more lives in crisis situations, if one dose were dispensed instead of the recommended two, new Johns Hopkins Bloomberg School of Public Health research suggests.
The Bill & Melinda Gates Foundation, NIH/National Institute of Allergy and Infectious Diseases

Contact: Stephanie Desmon
sdesmon1@jhu.edu
410-955-7619
Johns Hopkins University Bloomberg School of Public Health

Public Release: 25-Aug-2015
BMJ Quality Improvement Reports
Project in West Africa sees dramatic drop in TB death rates
Doctors in Togo, West Africa have seen a 10 percent drop in tuberculosis death rates after redesigning diagnosis and treatment services in one of the country's health districts.

Contact: Gozde Zorlu
gozde.zorlu@gmail.com
44-207-383-6920
BMJ

Public Release: 25-Aug-2015
PLOS Medicine
One dose or 2? Cholera vaccination strategies
A new modeling study appearing this week in PLOS Medicine supports consideration of vaccination campaigns using a single dose of cholera vaccine versus campaigns using the recommended two doses given two weeks apart. Justin Lessler and colleagues focus their modelling analyses on comparing the number of lives that could be saved by adopting a single vaccine dose, which could be more rapidly administered to more people than the internationally licensed two dose protocol.

Contact: Press Office
medicinepress@plos.org
PLOS

Public Release: 24-Aug-2015
2015 International Conference on Emerging Infectious Diseases
Is MERS another SARS: The facts behind Middle East Respiratory Syndrome
Experts show that while Middle East Respiratory Syndrome, a viral respiratory illness, is infecting less people, it has a higher mortality rate and affects a specific target population when compared to Severe Acute Respiratory Syndrome. This research is being presented at the International Conference on Emerging and Infectious Diseases in Atlanta, Georgia.

Contact: Aleea Khan
akhan@asmusa.org
202-942-9297
American Society for Microbiology

Public Release: 24-Aug-2015
Proceedings of the National Academy of Sciences
Tiny antibodies point to vulnerability in disease-causing parasites
By teasing apart the structure of an enzyme vital to the parasites that cause toxoplasmosis and malaria, Whitehead Institute scientists have identified a potentially 'druggable' target that could prevent parasites from entering and exiting host cells.
National Institutes of Health, US Department of Energy, National Science Foundation, German Academic Exchange Service

Contact: Nicole Giese Rura
rura@wi.mit.edu
617-258-6851
Whitehead Institute for Biomedical Research

Public Release: 21-Aug-2015
Global Health: Science and Practice
New diagnostic tools for dehydration severity in children
Dehydration from diarrhea, either viral or from cholera, kills 700,000 children a year worldwide, yet clinicians still lack a method that performs significantly better than chance for diagnosing dehydration severity. In a new study, researchers report two sensitive and specific diagnostic tools derived from the cases of hundreds of young children in Bangladesh.
NIH Fogarty International Center

Contact: David Orenstein
david_orenstein@brown.edu
401-863-1862
Brown University

Public Release: 20-Aug-2015
2015 World Congress on Health and Biomedical Informatics
There is lots of health data out there, how can it be used it to improve health care?
Regenstrief Institute investigators experienced in the use of data to improve health care and its delivery in resource constrained environments will introduce attendees at MedInfo 2015 to open source options for health information exchange and data analysis.

Contact: Cindy Fox Aisen
caisen@Iupui.edu
317-843-2276
Indiana University

Public Release: 19-Aug-2015
ACC, Apollo Hospitals partner to expand medical education offerings in India
The American College of Cardiology is collaborating with Apollo Hospitals in India to provide the College's guideline-driven educational content to physicians participating in Apollo's Medvarsity e-learning program, India's first medical e-learning venture.

Contact: Katie Glenn
kglenn@acc.org
202-375-6472
American College of Cardiology

Public Release: 18-Aug-2015
AIDS
Agricultural intervention improves HIV outcomes
A multifaceted farming intervention can reduce food insecurity while improving HIV outcomes in patients in Kenya, according to a randomized, controlled trial led by researchers at UC San Francisco.
NIH/National Institute of Mental Health, UC Global Health Institute Center of Expertise in Women's Health & Empowerment

Contact: Jeff Sheehy
Jeff.Sheehy@ucsf.edu
415-845-1132
University of California - San Francisco

Public Release: 18-Aug-2015
eLife
'Molecular tweezer' targets HIV and prevents semen from promoting infection
Semen can enhance HIV infectivity by up to 10,000 times so targeting the proteins responsible as well as the infection itself provides an 'unprecedented' dual protection. The specificity of the compound described also means it could have less side effects.

Contact: Zoe Dunford
z.dunford@elifesciences.org
44-077-863-03597
eLife

Showing releases 851-875 out of 1318.

<< < 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 > >>